BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1842684)

  • 1. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study.
    Faivre J; Arveux P; Milan C; Durand G; Lamour J; Bedenne L
    Eur J Cancer Prev; 1991 Oct; 1(1):49-55. PubMed ID: 1842684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary results of a mass screening program for colorectal cancer].
    Bedenne L; Durand G; Faivre J; Milan C; Boutron MC; Arveux P; Colombier P; Klepping C
    Gastroenterol Clin Biol; 1990; 14(2):140-5. PubMed ID: 2328881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participants' characteristics in a French colorectal cancer mass screening campaign.
    Herbert C; Launoy G; Thezee Y; Maurel J; Richir B; Reaud JM; Ollivier V; Pegulu L; Valla A; Gignoux M
    Prev Med; 1995 Sep; 24(5):498-502. PubMed ID: 8524725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [General practitioners' experience in a mass screening campaign of colorectal cancers].
    Durand G; Arveux P; Milan C; Quelier C; Bedenne L; Faivre J
    Cah Sociol Demogr Med; 1992; 32(2-3):191-205. PubMed ID: 1297544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost of a mass screening program for colorectal cancer using the occult blood test].
    Arveux P; Faivre J; Bedenne L; Durand G; Milan C; Milan C
    Gastroenterol Clin Biol; 1992; 16(6-7):547-51. PubMed ID: 1526416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French colorectal cancer screening pilot programme: results of the first round.
    Goulard H; Boussac-Zarebska M; Ancelle-Park R; Bloch J
    J Med Screen; 2008; 15(3):143-8. PubMed ID: 18927097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acceptability of the Hemoccult test in general medical practice. Results of a pilot study].
    Archambault F; Durand G; Faivre J; Voilquin JP; Archambault P; Riou F; Ageorges P; Archambault ML; Delville JM; Fesneau M
    Bull Cancer; 1989; 76(10):1071-5. PubMed ID: 2699722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mass screening for colorectal cancer].
    Faivre J; Tazi MA; Launoy G
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simultaneous screening of cancers of the breast, cervix, colon and rectum. The Isère experience].
    Exbrayat C; Garnier A; Bolla M; Winckel P; Salicru B; Marron J; Faure H; Menegoz F; Billette de Villemeur A
    Bull Cancer; 1996 Aug; 83(8):641-8. PubMed ID: 8869044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The North Coast Cholesterol Check Campaign. Results of the first three years of a large-scale public screening programme.
    van Beurden EK; James R; Henrikson D; Tyler C; Christian J
    Med J Aust; 1991 Mar; 154(6):385-91. PubMed ID: 2000051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal cancer. Knowledge of the public and acceptability of early detection in non-hospital medical practice].
    Bost R; Isnard H; Uhry A; Connard J
    Gastroenterol Clin Biol; 1987; 11(6-7):493-9. PubMed ID: 3609646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for cancer of the large intestine].
    Gnauck R
    Wien Med Wochenschr; 1988 Jun; 138(11-12):257-60. PubMed ID: 3051684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screen compliance rates in 14-years annual screening program for colorectal cancer with immunochemical fecal occult blood test-- identification of higher priority subjects in health education.
    Wei N; Nakama H; Li T
    Eur J Med Res; 1998 Jul; 3(7):341-4. PubMed ID: 9682030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.